SourcingAI
Try for free
Powered by Made-in-China.com
Enoxaparin Sodium Injection 60mg/0.6ml GMP Shinepharm
US$0.036-0.45
10,000 boxes
Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

For external use

Model NO.

AMC14084-02

Suitable for

Elderly, Children, Adult

State

Liquid

Shape

Liquid

Type

Western Medicines

Pharmaceutical Technology

Chemical Synthesis

Registration Dossiers

Available

Shelf Life

3 Years

Transport Package

2's/Box

Specification

60MG/0.6ML

Trademark

MEDIPHARM/OEM

Origin

China

HS Code

3004201700

Production Capacity

25, 000 Boxes

Key features

GMP Certified Manufacturing: Produced under strict GMP standards ensuring high quality and safety.
Versatile Clinical Indications: Effective for DVT prophylaxis, treatment, and acute myocardial infarction management.
Flexible Customization Options: Offers customization from designs, samples, and full customization services.
Registration Dossiers Available: Supports regulatory compliance with available registration dossiers.
Established Export Experience: 14 years of export experience with 80-100% repeat buyer rate.
Professional R&D Team: Backed by 5 R&D engineers and continuous new product launches.
Global Market Reach: Exports to South America, Southeast Asia, Africa, and South Asia.
Stable Supply Chain: Strong supply chain with 12 partners and consistent annual revenue.

Company profile

Anhui Medipharm Co., Ltd.
Years of Export ExperienceHigh Repeat Buyers ChoiceImporters and ExportersManagement Certification
Business Type: Manufacturer/Factory, Trading Company CertifiedR&D Capacity: ODM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 14 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤2.14h

AI-Powered supplier vetting

SummaryAnhui Medipharm Co., Ltd. is a China-based trading company established in 2010 with 32 employees and a broad healthcare-related product scope. It has overseas agents or branches, participated in the 136th Canton Fair, and exports 90% of total sales, but no overseas showroom is reported. Service procedures, corrective and preventive action procedures, and complaint-handling procedures are documented and supported by records. The supplier reports ISO9001:2015, ISO45001:2018, and ISO14001 certifications, although it lacks a factory environmental impact assessment report. Innovation and customization are supported by recent new products, ODM services, and multiple customization methods. Production capability is not demonstrated because the supplier is identified as a trading company and no manufacturing capacity is provided. Financial information only identifies reporting years, without substantive performance data. No specific customer cases are provided.
Supplier typeThe supplier is identified as a trading company or trade company, organized as a limited company in Hefei, Anhui, China, with 32 employees. Its listed product scope covers medicines, veterinary drugs, nutritional and medical products, additives, APIs, and related categories, indicating broad trading coverage rather than confirmed in-house manufacturing.
CertificationsThe supplier reports ISO9001:2015, ISO45001:2018, and ISO14001 certifications. However, it also reports no factory environmental impact assessment report; this does not negate the stated certifications but indicates incomplete environmental documentation for factory-related assessment.
After-Sales capabilityThe supplier has overseas agents or branches, has participated in the 136th Canton Fair, and serves listed markets including Papua New Guinea and Cameroon. Written procedures and records exist for service assessment, corrective and preventive actions, and customer complaints, while stated peak- and off-season lead times are both one month.
R&D capabilityThe supplier reports launching new products during the past year and provides ODM services, supporting active product development. It does not provide an SDK and does not offer OEM services for well-known brands, so the evidence supports product innovation but not software-development or major-brand OEM capability.
Customization capabilityThe supplier reports customization from designs, customization from samples, and full customization, as well as ODM service availability. These statements explicitly support a broad customization offering, although the evidence does not quantify capacity or specify production ownership.

Product Q&A

Q:What is the dosage and administration method?
A:
Administer by intravenous or subcutaneous injection only. Do not use intramuscular injection. Evaluate for bleeding disorders before starting.
Q:What are the main indications for Enoxaparin Sodium Injection?
A:
It is indicated for prophylaxis of deep vein thrombosis (DVT), treatment of acute DVT, and management of unstable angina and acute myocardial infarction.
Q:What are the key precautions and warnings?
A:
Key risks include hemorrhage, bleeding following PCI, heparin-induced thrombocytopenia, and serious adverse reactions in infants due to benzyl alcohol preservative.
Q:What are the contraindications for this medication?
A:
Contraindicated in patients with active major bleeding, history of immune-mediated HIT, or known hypersensitivity to enoxaparin sodium or heparin.
Q:What are the terms of payment and minimum order quantity?
A:
Minimum Order Quantity is 1000 Pieces. Payment terms include T/T, LC, and D/P.

Send Inquiry

*To:Anhui Medipharm Co., Ltd.Anhui Medipharm Co., Ltd.
*Content:
0/4000

Supplier replies will be sent to your registered email

You may also like

Sodium Pentahydyoxycaproate; Pasexon100t 527-07-1
Made-in-China.com